| The Carrolton Of Dunn | |
| 711 Susan Tart Road, Dunn, North Carolina 28335 | |
| (910) 892-8843 | |
| Name | The Carrolton Of Dunn |
|---|---|
| Location | 711 Susan Tart Road, Dunn, North Carolina |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 63.1% |
| Medicare ID (CCN) | 345325 |
| Legal Business Name | The Carrolton Of Dunn, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1346851052 |
| Organization Name | THE CARROLTON OF DUNN, LLC |
| Address | 711 Susan Tart Rd, Dunn, NC 28334 |
| Phone Number | 910-892-8843 |
News Archive
For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to "see" single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.
Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.
Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the acquisition of a medical office building located in Stockbridge, Georgia for approximately $8,140,000.
Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
› Verified 3 days ago
| NPI Number | 1831125335 |
| Organization Name | MAPLE LTC GROUP, LLC |
| Doing Business As | CORNERSTONE NURSING AND REHABILITATION CENTER |
| Address | 711 Susan Tart Rd, Dunn, NC 28334 |
| Phone Number | 910-892-8843 |
News Archive
For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to "see" single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.
Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.
Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the acquisition of a medical office building located in Stockbridge, Georgia for approximately $8,140,000.
Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to "see" single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.
Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.
Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the acquisition of a medical office building located in Stockbridge, Georgia for approximately $8,140,000.
Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $3250 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.28 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.87 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 20.37 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.43 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.35 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 12.6 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.37 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.83 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 2 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 78.51 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 42.34 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.88 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.95 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.69 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 54.5 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 77.85 | 82.93 |
News Archive
For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to "see" single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.
Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.
Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the acquisition of a medical office building located in Stockbridge, Georgia for approximately $8,140,000.
Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
› Verified 3 days ago
Harnett Woods Nursing And Rehabilitation Center Location: 604 Lucas Road, Dunn, North Carolina 28334 Phone: (910) 891-4600 |